Oracle Runs

Will the results be positive?

Trial terminated, est primary completion Feb 2026, current date Apr 2026. No public readout, results, or ORR data found in web searches across clinicaltrials.gov mirrors, Pfizer sites, news, or pubs. No sponsor press releases or analyst commentary framing positive/negative outcome. Evidence incomplete, no trial-specific interpretation.

Will the results be positive?

Trial (PORTSIDE, NCT05926960) is listed as terminated with primary completion in 2026. No public results, ORR data, press releases, or sponsor statements frame it as positive or negative. All sources are pre-result descriptions or listings of the ongoing/terminated study.

Will the results be positive?

ClinicalTrials.gov lists this study as terminated but without posted results, so there is no clear public trial-specific basis yet to call the readout positive or negative.

Will the results be positive?

No clear trial-specific efficacy readout was found. The public evidence indicates NCT05926960 was terminated for recruitment failure, and the ClinicalTrials.gov record snippet shows no posted results date. That supports lack of an interpretable positive/negative readout rather than a negative efficacy outcome.

Will the results be positive?

No trial-specific efficacy readout was found. Live sources show this Phase 2 study remained listed without posted results on sponsor/registry pages, and a later web source says it was terminated for inability to recruit the target number of patients. That supports lack of interpretable outcome, not positive or negative efficacy.